LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 897

Search options

  1. Article ; Online: Platelet antiaggregation after an acute coronary syndrome: what about the elderly?

    Huber, Kurt

    European heart journal

    2022  

    Language English
    Publishing date 2022-11-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehac405
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Scores for outcome prediction in patients admitted with cardiogenic shock.

    Huber, Kurt

    European heart journal

    2021  Volume 42, Issue 24, Page(s) 2353–2355

    MeSH term(s) Humans ; Myocardial Infarction ; Prognosis ; Shock, Cardiogenic/etiology
    Language English
    Publishing date 2021-06-10
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehab211
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The Association for Acute Cardiovascular Care.

    Huber, Kurt

    European heart journal

    2020  Volume 41, Issue 41, Page(s) 3977–3978

    Language English
    Publishing date 2020-10-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehaa562
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book ; Conference proceedings: Proceedings of the International Symposium "Update in Thrombolysis 2000 - Arteriosclerosis, Thrombosis and Cardiovascular Biology"

    Huber, Kurt

    October 12 - 14, 2000, Vienna, Austria

    (Thrombosis research ; 103, Suppl. 1)

    2001  

    Event/congress International Symposium Update in Thrombolysis 2000 - Arteriosclerosis, Thrombosis and Cardiovascular Biology (2000, Wien)
    Author's details guest ed.: Kurt Huber
    Series title Thrombosis research ; 103, Suppl. 1
    Collection
    Language English
    Size S149 S. : Ill., graph. Darst.
    Publisher Pergamon
    Publishing place Amsterdam u.a.
    Publishing country United States
    Document type Book ; Conference proceedings
    HBZ-ID HT013190778
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  5. Article ; Online: Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease.

    Verheugt, Freek W A / Huber, Kurt

    Thrombosis and haemostasis

    2023  Volume 123, Issue 2, Page(s) 133–134

    MeSH term(s) Humans ; Cardiovascular Diseases/drug therapy ; Platelet Aggregation Inhibitors/therapeutic use ; Aspirin/therapeutic use ; Drug Therapy, Combination
    Chemical Substances Platelet Aggregation Inhibitors ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2023-01-05
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 518294-3
    ISSN 2567-689X ; 0340-6245
    ISSN (online) 2567-689X
    ISSN 0340-6245
    DOI 10.1055/s-0042-1760129
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Guideline recommendations for cangrelor should be upgraded: pros and cons.

    Dangas, George / Nicolas, Johny / Harbich, Paul / Huber, Kurt

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

    2024  Volume 20, Issue 7, Page(s) e405–e407

    MeSH term(s) Humans ; Surveys and Questionnaires ; Decision Making ; Adenosine Monophosphate/therapeutic use ; Adenosine Monophosphate/analogs & derivatives ; Platelet Aggregation Inhibitors/therapeutic use ; Purinergic P2Y Receptor Antagonists
    Chemical Substances cangrelor (6AQ1Y404U7) ; Adenosine Monophosphate (415SHH325A) ; Platelet Aggregation Inhibitors ; Purinergic P2Y Receptor Antagonists
    Language English
    Publishing date 2024-04-01
    Publishing country France
    Document type Journal Article
    ZDB-ID 2457174-X
    ISSN 1969-6213 ; 1774-024X
    ISSN (online) 1969-6213
    ISSN 1774-024X
    DOI 10.4244/EIJ-E-23-00070
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The use of mechanical circulatory support in elective high-risk percutaneous coronary interventions: a literature-based review.

    Geppert, Alexander / Mashayekhi, Kambis / Huber, Kurt

    European heart journal open

    2024  Volume 4, Issue 2, Page(s) oeae007

    Abstract: Contemporary medical practices allow complete percutaneous coronary intervention (PCI) in a considerable number of patients who previously would have been considered too 'high-risk' for such procedures. The use of mechanical circulatory support (MCS) ... ...

    Abstract Contemporary medical practices allow complete percutaneous coronary intervention (PCI) in a considerable number of patients who previously would have been considered too 'high-risk' for such procedures. The use of mechanical circulatory support (MCS) devices during these high-risk PCIs (HR-PCIs) is thought to reduce the potential risk for major adverse events during and after revascularization. The intra-aortic balloon pump (IABP), veno-arterial extracorporeal membrane oxygenation (V-A ECMO), and the Impella are the most common MCS devices in use. This review aims to summarize the clinical evidence for each of these devices and the potential mechanisms for the improvement in patient outcomes in HR-PCI. The IABP use has rapidly declined in recent years due to no evidence of benefit in HR-PCI and cardiogenic shock. The V-A ECMO results in low rates of major adverse cardiac and cerebrovascular events (MACCEs) but higher rates of acute kidney injury and increased need for transfusions. In initial studies, Impella resulted in a reduced need for repeat interventions and reduced rates of hypotension, but no benefit in mortality. However, MACCE rates with Impella have gradually declined over the last 10 years, reflecting increased operator experience and technical improvements. Thus, a large, randomized trial is needed to assess the efficacy of Impella in HR-PCI with contemporary standards of care. There is currently no individual parameter that can identify patients who would benefit from MCS use in elective HR-PCI. To address this gap, we propose an algorithm that combines anatomical complexity, comorbidities, and clinical presentation to accurately identify candidates for MCS-assisted HR-PCI.
    Language English
    Publishing date 2024-02-09
    Publishing country England
    Document type Journal Article ; Review
    ISSN 2752-4191
    ISSN (online) 2752-4191
    DOI 10.1093/ehjopen/oeae007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Book ; Online: Fast Facts

    Gurbel, Paul A. / Tantry, Udaya S. / Huber, Kurt

    Acute Coronary Syndromes

    (Fast facts)

    2014  

    Abstract: Fast Facts: Acute Coronary Syndromes is an international evidence-based primer that focuses on optimizing patient outcomes via accurate initial diagnosis, appropriate risk stratification and proper therapeutic decision-making in line with both American ... ...

    Author's details Paul A. Gurbel, Udaya S. Tantry, Kurt Huber
    Series title Fast facts
    Abstract Fast Facts: Acute Coronary Syndromes is an international evidence-based primer that focuses on optimizing patient outcomes via accurate initial diagnosis, appropriate risk stratification and proper therapeutic decision-making in line with both American and European management guidelines.
    Keywords Coronary heart disease
    Subject code 616.1 ; 616.1/23 ; 616.123
    Language English
    Dates of publication 2014-2014
    Size 1 online resource (130 p.)
    Edition First edition January 2014.
    Publisher Health Press
    Publishing place Abingdon, England
    Document type Book ; Online
    Note English ; Includes index.
    ISBN 1-908541-58-X ; 1-908541-57-1 ; 1-306-95707-9 ; 1-908541-47-4 ; 978-1-908541-58-1 ; 978-1-908541-57-4 ; 978-1-306-95707-6 ; 978-1-908541-47-5
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  9. Article ; Online: Is Treatment of ST-Segment-Elevation Myocardial Infarction Patients With Ticagrelor or Other P2Y

    Huber, Kurt

    Circulation. Cardiovascular interventions

    2018  Volume 11, Issue 3, Page(s) e006555

    MeSH term(s) Humans ; Percutaneous Coronary Intervention ; ST Elevation Myocardial Infarction ; Ticagrelor
    Chemical Substances Ticagrelor (GLH0314RVC)
    Language English
    Publishing date 2018-06-05
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2450797-0
    ISSN 1941-7632 ; 1941-7640
    ISSN (online) 1941-7632
    ISSN 1941-7640
    DOI 10.1161/CIRCINTERVENTIONS.118.006555
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Current Definitions of Non-ST-Segment Elevation Myocardial Infarction: Challenges for Further Improvement.

    Huber, Kurt

    JACC. Cardiovascular interventions

    2018  Volume 11, Issue 9, Page(s) 865–867

    MeSH term(s) Humans ; Myocardial Infarction ; Non-ST Elevated Myocardial Infarction ; Percutaneous Coronary Intervention ; Prognosis ; Treatment Outcome
    Language English
    Publishing date 2018-05-10
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2452157-7
    ISSN 1876-7605 ; 1936-8798
    ISSN (online) 1876-7605
    ISSN 1936-8798
    DOI 10.1016/j.jcin.2018.03.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top